Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 2
1978 1
1979 5
1980 4
1981 4
1983 3
1984 5
1985 3
1986 2
1987 1
1988 1
1989 5
1990 4
1991 5
1992 7
1993 8
1994 8
1995 3
1996 6
1997 16
1998 10
1999 9
2000 9
2001 11
2002 13
2003 10
2004 8
2005 4
2006 13
2007 6
2008 11
2009 13
2010 11
2011 9
2012 18
2013 12
2014 13
2015 16
2016 14
2017 17
2018 14
2019 15
2020 9
2021 14
2022 22
2023 16
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Glucocorticoid deficiency 5"
Page 1
Should Dehydroepiandrosterone Be Administered to Women?
Wierman ME, Kiseljak-Vassiliades K. Wierman ME, et al. J Clin Endocrinol Metab. 2022 May 17;107(6):1679-1685. doi: 10.1210/clinem/dgac130. J Clin Endocrinol Metab. 2022. PMID: 35254428 Free PMC article. Review.
No consistent beneficial effects of DHEA administration have been observed for menopausal symptoms, sexual function, cognition, or overall wellbeing in normal women. ...CLINICAL CASE: A 49-year-old woman with Addison's disease who is on low dose estrogen with cyclic proges …
No consistent beneficial effects of DHEA administration have been observed for menopausal symptoms, sexual function, cognition, or ov …
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
Merke DP, Mallappa A, Arlt W, Brac de la Perriere A, Lindén Hirschberg A, Juul A, Newell-Price J, Perry CG, Prete A, Rees DA, Reisch N, Stikkelbroeck N, Touraine P, Maltby K, Treasure FP, Porter J, Ross RJ. Merke DP, et al. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2063-e2077. doi: 10.1210/clinem/dgab051. J Clin Endocrinol Metab. 2021. PMID: 33527139 Free PMC article. Clinical Trial.
CONTEXT: Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes. ...METHODS: A 6-month, randomized, phase 3 study was conducted of MR-HC vs stan …
CONTEXT: Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing …
How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge.
Akwaa F, Antun A, Cataland SR. Akwaa F, et al. Blood. 2022 Aug 4;140(5):438-444. doi: 10.1182/blood.2021014514. Blood. 2022. PMID: 35667044 Free article. Review.
Immune-mediated thrombocytopenic purpura (iTTP) is a thrombotic microangiopathy characterized by an acquired ADAMTS13 deficiency as a result of the presence of an antibody inhibitor of ADAMTS13 leading to the formation of ultralarge von Willebrand multimers. Treatment of i …
Immune-mediated thrombocytopenic purpura (iTTP) is a thrombotic microangiopathy characterized by an acquired ADAMTS13 deficiency as a …
X-linked adrenoleukodystrophy and primary adrenal insufficiency.
Cappa M, Todisco T, Bizzarri C. Cappa M, et al. Front Endocrinol (Lausanne). 2023 Nov 16;14:1309053. doi: 10.3389/fendo.2023.1309053. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38034003 Free PMC article. Review.
Novel approaches, such as prolonged release glucocorticoids, offer potential benefit in optimizing hormonal replacement for X-ALD-related PAI. Although the association between PAI and X-ALD has been observed in clinical practice, the underlying mechanisms remain poo …
Novel approaches, such as prolonged release glucocorticoids, offer potential benefit in optimizing hormonal replacement for X-ALD-rel …
Glucocorticoid-induced osteoporosis.
Reid IR. Reid IR. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Jun;14(2):279-98. doi: 10.1053/beem.2000.0074. Baillieres Best Pract Res Clin Endocrinol Metab. 2000. PMID: 11035907 Review.
Virtually all patients receiving glucocorticoids in doses above 5 mg per day lose bone, the amount lost being dependent on the cumulative steroid dose. ...Increasing the calcium intake to 1.5 g per day, encouraging them to stop smoking and take more exercise, …
Virtually all patients receiving glucocorticoids in doses above 5 mg per day lose bone, the amount lost being dependent on the …
Common Oral Conditions: A Review.
Stoopler ET, Villa A, Bindakhil M, Díaz DLO, Sollecito TP. Stoopler ET, et al. JAMA. 2024 Mar 26;331(12):1045-1054. doi: 10.1001/jama.2024.0953. JAMA. 2024. PMID: 38530258 Review.
Symptoms may include difficulty swallowing and speaking, thirst, and halitosis. Dry mouth is associated with an 11.5% (95% CI, 3.6% to 27%) higher risk of oral candidiasis, based on a meta-analysis of 6 observational cohorts. ...Another meta-analysis of 9 case-contr …
Symptoms may include difficulty swallowing and speaking, thirst, and halitosis. Dry mouth is associated with an 11.5% (95% CI, 3.6% t …
Hyaline membrane disease.
Farrell PM, Avery ME. Farrell PM, et al. Am Rev Respir Dis. 1975 May;111(5):657-88. doi: 10.1164/arrd.1975.111.5.657. Am Rev Respir Dis. 1975. PMID: 1093459 Review.
Prenatal assessment of the risk for developing the disorder is now routinely possible by amniocentesis and analysis of the ratio of lecithin to sphingomyelin in amniotic fluid, or by surfactant titer ("shake test"). Such predictability and numerous other lines of evidence …
Prenatal assessment of the risk for developing the disorder is now routinely possible by amniocentesis and analysis of the ratio of lecithin …
Celiac disease and idiopathic pulmonary hemosiderosis: a literature review of the Lane-Hamilton syndrome.
Tryfon S, Papadopoulou E, Psarros G, Agrafiotis M, Saroglou M. Tryfon S, et al. Postgrad Med. 2022 Nov;134(8):732-742. doi: 10.1080/00325481.2022.2109121. Epub 2022 Aug 8. Postgrad Med. 2022. PMID: 35912848 Review.
Hemoptysis (n = 56, 70%), dyspnea (n = 47, 58.8%), anemia (n = 72, 90%), and iron deficiency (n = 54, 67.5%) were most commonly observed. Medical history revealed recurrent episodes of hemoptysis (n = 38) and persistent iron deficiency anemia (n = 25) …
Hemoptysis (n = 56, 70%), dyspnea (n = 47, 58.8%), anemia (n = 72, 90%), and iron deficiency (n = 54, 67.5%) were most commonl …
Human studies on hypothalamo-pituitary-adrenal (HPA) axis.
Liyanarachchi K, Ross R, Debono M. Liyanarachchi K, et al. Best Pract Res Clin Endocrinol Metab. 2017 Oct;31(5):459-473. doi: 10.1016/j.beem.2017.10.011. Epub 2017 Nov 2. Best Pract Res Clin Endocrinol Metab. 2017. PMID: 29223281 Review.
The daily rhythm of the hypothalamo-pituitary-adrenal (HPA) axis is regulated by the central clock in the suprachiasmatic nucleus. Cortisol, a glucocorticoid, acts as a secondary messenger between the central clock and the peripheral tissues. ...Depression, anorexia nervos …
The daily rhythm of the hypothalamo-pituitary-adrenal (HPA) axis is regulated by the central clock in the suprachiasmatic nucleus. Cortisol, …
Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.
Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV. Joshi MN, et al. Clin Endocrinol (Oxf). 2016 Sep;85(3):331-9. doi: 10.1111/cen.13063. Epub 2016 Apr 13. Clin Endocrinol (Oxf). 2016. PMID: 26998595 Review.
The mean onset of endocrine side effects is 9 weeks after initiation (range 5-36 weeks). Investigation and/or screening for hypophysitis requires biochemical and radiological assessment. Hypopituitarism is treated with replacement doses of deficient hormones. Since …
The mean onset of endocrine side effects is 9 weeks after initiation (range 5-36 weeks). Investigation and/or screening for hypophysi …
381 results